Skip to main content
Top
Published in: European Journal of Nutrition 2/2021

01-03-2021 | Original Contribution

Dietary glycemic index, glycemic load and risk of bladder cancer: a prospective study

Authors: Xin Xu, Nitin Shivappa

Published in: European Journal of Nutrition | Issue 2/2021

Login to get access

Abstract

Purpose

Previous studies have provided limited evidence for an adverse effect of high glycemic index (GI) and glycemic load (GL) on bladder cancer risk. This study aimed to examine the association between GI, GL and bladder cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Methods

GI and GL scores were computed among 101,721 participants in the PLCO study. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression model adjusting for confounders.

Results

After a median of 12.5 years of follow-up, 776 incident bladder cancer cases occurred. There was no significant association between bladder cancer risk and GI (HRQ5vsQ1 = 1.18, 95% CI 0.94–1.48, p for trend = 0.177) or GL (HRQ5vsQ1 = 0.92, 95% CI 0.65–1.30, p for trend = 0.826). The associations did not differ by continuous analyses. Spline regression plots revealed a lower risk of bladder cancer with higher GI or GL, but the difference was not statistically significant. There was no statistical evidence for nonlinearity (P for nonlinearity > 0.05).

Conclusion

In summary, analysis of the PLCO cohort did not provide evidence that higher GI or GL diets were associated with greater bladder cancer risk.
Appendix
Available only for authorised users
Literature
10.
go back to reference Augustin LSA, Taborelli M, Montella M, Libra M, La Vecchia C, Tavani A, Crispo A, Grimaldi M, Facchini G, Jenkins DJA, Botti G, Serraino D, Polesel J (2017) Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control study. Br J Nutr 118(9):722–729. https://doi.org/10.1017/s0007114517002574CrossRefPubMed Augustin LSA, Taborelli M, Montella M, Libra M, La Vecchia C, Tavani A, Crispo A, Grimaldi M, Facchini G, Jenkins DJA, Botti G, Serraino D, Polesel J (2017) Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control study. Br J Nutr 118(9):722–729. https://​doi.​org/​10.​1017/​s000711451700257​4CrossRefPubMed
12.
go back to reference Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O’Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21(6 Suppl):273S–309SCrossRef Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O’Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21(6 Suppl):273S–309SCrossRef
25.
go back to reference Flood A, Peters U, Jenkins DJA, Chatterjee N, Subar AF, Church TR, Bresalier R, Weissfeld JL, Hayes RB, Schatzkin A, Prostate LCOPT (2006) Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study. Am J Clin Nutr 84(5):1184–1192. https://doi.org/10.1093/ajcn/84.5.1184CrossRefPubMed Flood A, Peters U, Jenkins DJA, Chatterjee N, Subar AF, Church TR, Bresalier R, Weissfeld JL, Hayes RB, Schatzkin A, Prostate LCOPT (2006) Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study. Am J Clin Nutr 84(5):1184–1192. https://​doi.​org/​10.​1093/​ajcn/​84.​5.​1184CrossRefPubMed
Metadata
Title
Dietary glycemic index, glycemic load and risk of bladder cancer: a prospective study
Authors
Xin Xu
Nitin Shivappa
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2021
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02313-1

Other articles of this Issue 2/2021

European Journal of Nutrition 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.